Review Article
Quorum Sensing: A Prospective Therapeutic Target for Bacterial Diseases
Table 1
Studies demonstrating the quorum sensing (QS) signaling disruption by receptor inactivation. Abbreviations: 3-oxo-C12, N-3-oxododecanoyl-C12; AHL, N-acyl-homoserine lactones; AI, autoinducer; C4‐LHL, butenyl homoserine lactones; C6‐LHL, hexanoyl homoserine lactones; HSL, L-homoserine lactone; PHL, propionyl homoserine lactones.
| Models | Strains | Anti-QS agents | Target | Effects | Ref |
| In-vitro | Pseudomonas aeruginosa | Flavonoids | Allosteric inhibition of AI-binding receptors, LasR and RhlR | Altered transcription of QS-controlled target promoters and suppresses virulence factor production | [53] | In-vitro | Pseudomonas aeruginosa PAO1 | N-decanoyl-L-homoserine benzyl ester | Activating quorum sensing control repressor | Attenuated the activity of protease and elastase, swarming motility and biofilm formation | [54, 55] | In-vitro, C. elegans, A549 cells, | Pseudomonas aeruginosa PA14 | Meta-bromo-thiolactone | Inhibition of LasR and RhlR | Inhibited both the production of the virulence factor pyocyanin and biofilm formation | [57] | In-vitro | Pseudomonas aeruginosa | AHL ligands A4, 4-bromophenyl-PHL B7, 4-iodo PHL C10, and 3-nitro PHL C14 | Binding to TraR, LasR, and LuxR | Strongly inhibited virulence factor production | [58] | In-vitro, Mice | Aeromonas hydrophila | C4- and C6-HSLs, 3-oxo-C12-HSL | Regulating the host immune receptor | Increased survivability of infected mice | [59] |
|
|